⚠ Scores are AI-generated estimates for informational purposes only — not investment advice. Data may be inaccurate or outdated. Do not make financial decisions based on this site. Full legal disclaimer →
⚠ Scores are AI-generated estimates for informational purposes only — not investment advice. Data may be inaccurate or outdated. Do not make financial decisions based on this site. Full legal disclaimer →
AI Exposure Analysis
Healthcare · Large Cap · Disruption threat: HIGH
Cigna leverages AI extensively for claims processing, prior authorization automation, and care management through its Evernorth segment, with ongoing investments in predictive analytics and clinical decision support. The company faces significant disruption risk as AI-driven competitors and regulatory scrutiny around automated claim denials intensify pressure on traditional managed care models.
Cigna (CI) is a large-cap managed care and health services company operating through its Evernorth and Cigna Healthcare segments. With an overall AI score of 62/100, the company demonstrates meaningful but uneven AI adoption, reflecting a business that has prioritized operational efficiency over AI-driven revenue generation. Internal AI use leads the scorecard at 75/100, reflecting mature deployment across claims adjudication, prior authorization automation, fraud detection, and utilization management. Product AI integration follows at 65/100, driven by predictive analytics for risk stratification and personalized member engagement within Evernorth. R&D investment and infrastructure both score 55/100, suggesting adequate but not differentiated commitment to next-generation capabilities. Revenue derived from AI remains the weakest dimension at 20/100, indicating that AI primarily reduces costs rather than generating new commercial streams. The HIGH disruption threat designation is significant. Cigna's core managed care model faces pressure from AI-native competitors offering more transparent, lower-cost alternatives, while regulatory scrutiny around automated claim denials creates compliance and reputational exposure. The same tools driving efficiency could become liabilities if AI-driven denial rates attract legislative action. The primary near-term opportunity lies in Evernorth's clinical decision support and virtual health navigation capabilities, which could differentiate pharmacy and benefits services if commercialized effectively across employer and government channels.
Full interactive analysis at RankVis.io